Skip to content

Prospective multi-center observational study for evaluating efficacy and safety of CENTUM ™, Everolimus-eluting stent in patients with coronary artery disease

Prospective multi-center observational study for evaluating efficacy and safety of CENTUM ™, Everolimus-eluting stent in patients with coronary artery disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009898
Enrollment
500
Registered
2024-11-04
Start date
2021-06-08
Completion date
Unknown
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult subjects (aged 19 years or older) who have provided written informed consent to participate in the post-procedure registry.

Exclusion criteria

Exclusion criteria: - Vulnerable research subjects who are unable to give informed consent - Pregnant

Design outcomes

Primary

MeasureTime frame
Target lesion failure (cardiac death, non-fatal MI, Composite endpoint of target lesion revascularization)

Secondary

MeasureTime frame
?Incidence of definite/probable stent thrombosis?Rates of the following clinical events: Death (cardiovascular, non-cardiovascular, undetermined), All-cause mortality All myocardial infarction All cerebrovascular events (ischemic or hemorrhagic), Target vessel revascularization and any revascularization, Bleeding (BARC bleeding score: 3a, 3b, 3c, 5)? Clinical and procedural success of the medical device

Countries

Korea, Republic of

Contacts

Public ContactJINKYUNG GO

Seoul National University Bundang Hospital

snubits.gjk@gmail.com+82-31-712-9005

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026